The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Prognostic value of mature MicroRNA-21 and MicroRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR
Open accessAbstract
Background: microRNA (miRNA) expression profiles are being intensively investigated for their involvement in carcinogenesis. We evaluated the prognostic value of mature microRNA-21 (miR-21) and mature microRNA-205 (miR-205) overexpression in non–small cell lung cancer (NSCLC). Patients and methods: We studied 48 pairs of NSCLC fresh frozen tissue specimens collected at time of surgery and before chemotherapy. Highly specific amplification and quantification of mature miR-21 and mature miR-205 was achieved using looped real time RT-PCR. Results: miRNA expression, determined by real time RT-PCR, was defined by ΔΔCt measurements. We detected overexpression of mature miR-21 in 25 (52.0%) of the 48 NSCLC paired specimens and overexpression of miR-205 in 31 (64.6%). Overexpression was assessed after comparison of miRNA expression in NSCLC tissues and in their corresponding noncancerous tissues with respect to U6 expression. During the follow-up period, 29 of 48 (60.4%) patients relapsed, and 23 of 48 died (47.9%). Mature miR-21 was upregulated in 16 of 29 (55.2%) patients who relapsed and 15 of 23 (65.2%) patients who died. Mature miR-205 was overexpressed in 19 of 29 patients who relapsed (65.5%) and 15 of 23 patients who died (65.2%). Mature miR-21 overexpression correlated with overall survival (OS) of the patients (P = 0.027), whereas overexpression of mature miR-205 did not. Conclusions: Our results suggest that overexpression of mature miR-21 is an independent negative prognostic factor for OS in NSCLC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recently, miR-21 expression levels have proven useful prognostic markers in non-small cell lung cancer (Markou et al., 2008; Yanaihara et al., 2006).”
From Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21 (2010) · cites this paper as Markou et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,989
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,096
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Flagged first, then by citations
Research works printed but not linked: 1
- 2006, Mol Vis, 12, 1175
Cited by
Sorted by citations
Items 201–300 of 440
Huang, Q., Liu, L., Liu, C., You, H., Shao, F., Xie, F., Lin, X., Hu, S., & Zhang, C. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.2.829 · Cited by 48
Weisong, L., Cui, Y., Wang, D., Wang, Y., & Wang, L. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.089 · Cited by 48
Wang, W., Li, X., Liu, C., Zhang, X., Wu, Y., Diao, M., Tan, S.-Y., Huang, S., Cheng, Y., & You, T. (2022) · Bioscience Reports · doi:10.1042/bsr20211653 · Cited by 47
Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer
Zaporozhchenko, I. A., Morozkin, E. S., Skvortsova, T. E., Ponomaryova, A. A., RYKOVA, E. Y., Чердынцева, Н. В., Polovnikov, E. S., Pashkovskaya, O. A., Pokushalov, E. A., Vlassov, V. V., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165261 · Cited by 48
Zheng, X., Dong, L., Zhao, S., Li, Q., Liu, D., Zhu, X., Ge, X., Li, R., & Wang, G. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004778 · Cited by 46
Liu, H., Bei, X., Xia, Q., Fu, Y., Zhang, S., Liu, M., Fan, K., Zhang, M., & Yang, Y. (2015) · Microchimica Acta · doi:10.1007/s00604-015-1636-z · Cited by 46
Simultaneously sensitive detection of multiple miRNAs based on a strand displacement amplification
Tian, T., Xiao, H., Zhang, X., Peng, S., Zhang, X., Guo, S., Wang, S., Liu, S., Zhou, X. M., Meyers, C., et al. (2012) · Chemical Communications · doi:10.1039/c2cc36728a · Cited by 46
MicroRNA in cancer: New hopes for antineoplastic chemotherapy
Leva, G. D., Briskin, D., & Croce, C. M. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.660551 · Cited by 47
Yang, Q., Yang, F., Dai, W., Meng, X., Wei, W., Cheng, Y., Dong, J., Lu, H., & Dong, H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101130 · Cited by 46
MicroRNA Expression Detection Methods
Wang, Z., & Yang, B. (2009) · Springer eBooks · doi:10.1007/978-3-642-04928-6 · Cited by 45
miREFRWR: a novel disease-related microRNA-environmental factor interactions prediction method
Chen, X. (2015) · Molecular BioSystems · doi:10.1039/c5mb00697j · Cited by 45
The role of mammalian ribonucleases (RNases) in cancer
Kim, W.-C., & Lee, C. H. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.05.002 · Cited by 44
Potential Role of Circulating microRNA-21 for Hepatocellular Carcinoma Diagnosis: A Meta-Analysis
Liao, Q., Han, P., Huang, Y., Wu, Z., Chen, Q., Li, S., Ye, J., & Wu, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130677 · Cited by 45
Zhang, J., Song, C., Zhu, Y., Gan, H., Fang, X., Peng, Q., Xiong, J., Dong, C., Han, C., & Wang, L. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114836 · Cited by 44
Kalogirou, C., Spahn, M., Krebs, M., Joniau, S., Lerut, E., Burger, M., Scholz, C. J., Kneitz, S., Riedmiller, H. N., & Kneitz, B. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121414 · Cited by 44
Bi, N., Cao, J., Song, Y., Shen, J., Liu, W., Fan, J., He, J., Shi, Y., Zhang, X., Lü, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091388 · Cited by 44
An update on sputum Micro RNA s in lung cancer diagnosis
Sheervalilou, R., Ansarin, K., Aval, S. F., Shirvaliloo, S., Pilehvar‐Soltanahmadi, Y., Mohammadian, M., & Zarghami, N. (2016) · Diagnostic Cytopathology · doi:10.1002/dc.23444 · Cited by 44
MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39
Guo, R., Gu, J., Zhang, Z., Wang, Y., & Gu, C. (2017) · BioMed Research International · doi:10.1155/2017/2381482 · Cited by 44
RetractedWang, Y., Zhang, Y., Pan, C., Ma, F., & Zhang, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118647 · Cited by 45
Kang, W. K., Lee, J., Oh, S. T., Lee, S. H., & Jung, C. K. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0227-0 · Cited by 44
Huo, L., Wang, Y., Gong, Y., Krishnamurthy, S., Wang, J., Diao, L., Liu, C., Liu, X., Lin, F., Symmans, W. F., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.38 · Cited by 43
Świtlik, W. Z., Karbownik, M. S., Suwalski, M., Kozak, J., & Szemraj, J. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170767 · Cited by 43
MiR ‐205‐5p promotes lung cancer progression and is valuable for the diagnosis of lung cancer
Zhao, Y., Zhang, J. R., Yang, J., Wei, Y., Peng, J., Fu, C., Huang, M., Wang, R., Wang, P., Sun, G., et al. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14331 · Cited by 43
Wilmott, J. S., Zhang, X. D., Hersey, P., & Scolyer, R. A. (2011) · Pathology · doi:10.1097/pat.0b013e32834a7358 · Cited by 41
Simultaneous downregulation of miR-21 and upregulation of miR-7 has anti-tumor efficacy
Bhere, D., Arghiani, N., Lechtich, E. R., Yao, Y., Alsaab, S. M., Bei, F., Matin, M. M., & Shah, K. (2020) · Scientific Reports · doi:10.1038/s41598-020-58072-w · Cited by 41
microRNAs as novel epigenetic biomarkers for human cancer
Cortés-Sempere, M., & de Cáceres, I. I. (2011) · Clinical & Translational Oncology · doi:10.1007/s12094-011-0668-z · Cited by 42
microRNA expression profiles in oral squamous cell carcinoma
SOGA, D., Yoshiba, S., Shiogama, S., Miyazaki, H., Kondo, S., & Shintani, S. (2013) · Oncology Reports · doi:10.3892/or.2013.2488 · Cited by 40
Alinovi, R., Goldoni, M., Pinelli, S., Ravanetti, F., Galetti, M., Pelosi, G., Palma, G. D., Apostoli, P., Cacchioli, A., Mutti, A., et al. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.04.007 · Cited by 40
MicroRNAs in cancer diagnosis and therapy: from bench to bedside
Hoshino, I., & Matsubara, H. (2012) · Surgery Today · doi:10.1007/s00595-012-0392-5 · Cited by 39
Izzotti, A., Larghero, P., Balansky, R. M., Pfeffer, U., Steele, V. E., & Flora, S. D. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.10.003 · Cited by 39
Sun, Z., Li, S., Kaufmann, A. M., & Albers, A. E. (2014) · Oncology Reports · doi:10.3892/or.2014.3456 · Cited by 39
Proteins are potent biomarkers to detect colon cancer progression
Kuppusamy, P., Govindan, N., Yusoff, M. M., & Ichwan, S. J. A. (2014) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.09.017 · Cited by 38
Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer
Sempere, L. F. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.69 · Cited by 37
Unpredictable changes of selected miRNA in expression profile of HNSCC
Lamperska, K. M., Kozłowski, P., Kolenda, T., Teresiak, A., Bliźniak, R., Przybyła, W., Masternak, M. M., Golusiński, P., & Golusiński, W. (2016) · Cancer Biomarkers · doi:10.3233/cbm-150540 · Cited by 37
Wang, X., Zhang, J., Zhou, L., Lu, P., Zheng, Z., Sun, W., Wang, J., Yang, X., Li, X.-L., Xia, N., et al. (2015) · Europe PMC (PubMed Central) · Cited by 37
Bowden, M., Zhou, C. W., Zhang, S., Brais, L. K., Rossi, A., Naudin, L., Thiagalingam, A., Sicińska, E., & Kulke, M. H. (2017) · Oncotarget · doi:10.18632/oncotarget.16908 · Cited by 37
Gallach, S., Lewintre, E. J., Fariñas, S. C., Montaner, D. A., Alonso, S., Sirera, R., Blasco, A., Usó, M., Guijarro, R., Martorell, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18603 · Cited by 37
MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
Wani, J. A., Majid, S., Imtiyaz, Z., Rehman, M. U., Alsaffar, R. M., Shah, N. N., Alshehri, S., Ghoneim, M. M., & Imam, S. S. (2022) · Diagnostics · doi:10.3390/diagnostics12071610 · Cited by 39
Non-coding RNAs in lung cancer
Ricciuti, B., Mecca, C., Crinò, L., Baglivo, S., Cenci, M., & Metro, G. (2014) · Oncoscience · doi:10.18632/oncoscience.98 · Cited by 38
Liu, K., Li, G., Fan, C., Zhou, X., Wu, B., & Li, J. (2011) · Journal of International Medical Research · doi:10.1177/147323001103900626 · Cited by 36
Epigenomic targets for the treatment of respiratory disease
Bowman, R., Wright, C. M., Davidson, M. R., Francis, S. M. S., Yang, I. A., & Fong, K. M. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220902926119 · Cited by 36
Zeng, Y., Zhu, J., Shen, D., Qin, H., Lei, Z., Li, W., Liu, Z., & Huang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10339 · Cited by 36
Shan, X., Zhang, H., Zhang, L., Xin Min, Z. H. O. U., Wang, T., Zhang, J., Shu, Y., Zhu, W., Wen, W., & Liu, P. (2018) · Cancer Medicine · doi:10.1002/cam4.1490 · Cited by 36
Lamichhane, S. R., Thachil, T., Ieso, P. B. D., Gee, H. E., Moss, S. A., & Milic, N. L. (2018) · Disease Markers · doi:10.1155/2018/8309015 · Cited by 36
Wang, J., Li, Z., Ge, Q., Wu, W., Zhu, Q., Luo, J., & Chen, L. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.02.012 · Cited by 36
MicroRNAs in human lung cancer
Kang, S., & Lee, H. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214533887 · Cited by 35
Chen, W., Hou, J., Guo, Y., Yang, H., Xie, C., Lin, Y., & She, Z. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-17 · Cited by 35
Du, Y., Liu, Z., Gu, L., Zhou, J., Zhu, B., Ji, J., & Deng, D. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-249 · Cited by 35
Wang, M., Shen, B., Yuan, R., Cheng, W., Xu, H., & Ding, S. (2015) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2015.08.026 · Cited by 34
Bioinformatics analysis of differentially expressed miRNAs in non‐small cell lung cancer
Yu, H., Pang, Z., Li, G., & Gu, T. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23588 · Cited by 34
Cho, W. C. S. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.57 · Cited by 34
Wang, T., Zang, W., Li, M., Wang, N., Zheng, Y., & Zhao, G. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2395-x · Cited by 33
RetractedPlasma miR-127 and miR-218 Might Serve as Potential Biomarkers for Cervical Cancer
You, W., Wang, Y., & Zheng, J. (2015) · Reproductive Sciences · doi:10.1177/1933719115570902 · Cited by 33
Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma
Tian, F., Li, R., Chen, Z., Shen, Y., Lu, J., Xie, X., & Ge, Q. (2016) · BioMed Research International · doi:10.1155/2016/1428271 · Cited by 34
MiR-205 as a promising biomarker in the diagnosis and prognosis of lung cancer
Li, J., Sun, S., Li, N., Lv, P., Xie, S., & Wang, P. (2017) · Oncotarget · doi:10.18632/oncotarget.20262 · Cited by 33
Predicting microRNA-disease associations using bipartite local models and hubness-aware regression
Chen, X., Cheng, J., & Yin, J. (2018) · RNA Biology · doi:10.1080/15476286.2018.1517010 · Cited by 33
Pharmacogenetics of Conventional Chemotherapy in Non-Small-Cell Lung Cancer: A Changing Landscape?
Giovannetti, E., Toffalorio, F., Pas, T. M. D., & Peters, G. J. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.91 · Cited by 34
Gao, W., Xu, J., & Shu, Y. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.55 · Cited by 32
miR-205 regulates A549 cells proliferation by targeting PTEN.
Bai, J., Zhu, X., Ma, J., & Wang, W. (2015) · Europe PMC (PubMed Central) · Cited by 32
miRNAs in Lung Cancer: Large Roles for Small Players
Cherni, I., & Weiss, G. J. (2011) · Future Oncology · doi:10.2217/fon.11.74 · Cited by 33
Kor, K., Turner, A. P. F., Zarei, K., Atabati, M., Beni, V., & Mak, W. C. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-9250-9 · Cited by 32
Serum/Plasma MicroRNAs as Biomarkers for HBV-Related Hepatocellular Carcinoma in China
Yin, W., Zhao, Y., Ji, Y.-J., Tong, L.-P., Liu, Y., He, S., & Wang, A.-Q. (2015) · BioMed Research International · doi:10.1155/2015/965185 · Cited by 32
Duan, Y., & Chen, Q. (2016) · Oncology Reports · doi:10.3892/or.2016.5023 · Cited by 32
Hosseini, S. M., Soltani, B. M., Tavallaei, M., Mowla, S. J., Tafsiri, E., Bagheri, A., & Khorshid, H. R. K. (2018) · Europe PMC (PubMed Central) · Cited by 31
Zhang, Q., Yan, H., Ru, C., Fu, Z., Zou, H. Y., Gao, P. F., Huang, C. Z., & Wang, J. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113942 · Cited by 31
Peng, W., Lan, W., Zhong, J., Wang, J., & Pan, Y. F. (2017) · Methods · doi:10.1016/j.ymeth.2017.05.024 · Cited by 31
An approach for prioritizing disease-related microRNAs based on genomic data integration
Jiang, Q., Wang, G., & Wang, Y. (2010) · International Conference on Biomedical Engineering and Informatics (BMEI) · doi:10.1109/bmei.2010.5639313 · Cited by 29
Predicting human microRNA-disease associations based on support vector machine
Jiang, Q., Wang, G., Zhang, T., & Wang, Y. (2010) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2010.5706611 · Cited by 29
Wang, M., Wang, Y., Tian, X., Wang, Q., Huang, H., Lu, X., Qi, M., Cao, X., & Lei, J. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2195552 · Cited by 31
Jiang, Z., Wang, H., Zhang, X., Liu, C., & Li, Z. (2014) · Analytical Methods · doi:10.1039/c4ay02142h · Cited by 28
Zhu, D., Liu, W., Cao, W., Chao, J., Su, S., Wang, L., & Fan, C. (2018) · Electroanalysis · doi:10.1002/elan.201700696 · Cited by 28
Pan, F., Mao, H., Deng, L., Li, G., & Geng, P. (2014) · PubMed · Cited by 27
Expression signatures and roles of microRNAs in inflammatory breast cancer
Qi, Y., Wang, X., Kong, X., Zhai, J., Fang, Y., Guan, X., & Wang, J. (2019) · Cancer Cell International · doi:10.1186/s12935-018-0709-6 · Cited by 27
Nasirian, V., Shamsipur, M., Molaabasi, F., Mansouri, K., Sarparast, M., Salim, V., Barati, A., & Kashanian, S. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.127673 · Cited by 27
Lin, L., Li, Y., Han, H., & Lin, S. (2021) · Aging · doi:10.18632/aging.202363 · Cited by 27
The Role of microRNAs in Lung Cancer: Mechanisms, Diagnostics and Therapeutic Potential
Bartoszewska, E., Misiąg, P., Czapla, M., Rakoczy, K., Tomecka, P., Filipski, M., Wawrzyniak-Dzierżek, E., & Choromańska, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083736 · Cited by 27
Noncoding RNAs: New Players in Pulmonary Medicine and Sarcoidosis
Salamó, O., Mortaz, E., & Mirsaeidi, M. S. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0196tr · Cited by 26
Ye, R., Wei, B., Li, S., Liu, W., Liu, J., Luan, Q., Wu, X., Zhao, Z., & Li, J. (2017) · Oncotarget · doi:10.18632/oncotarget.21919 · Cited by 26
microRNAs are important players in head and neck carcinoma: A review
Janiszewska, J., Szaumkessel, M., & Szyfter, K. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.07.012 · Cited by 26
Li, Y., Ye, J., Xu, S., & Wang, J. (2023) · Discover Oncology · doi:10.1007/s12672-023-00686-3 · Cited by 27
Zayani, R., Rabti, A., Aoun, S. B., & Raouafi, N. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128950 · Cited by 25
Seo, S., Moon, Y., Choi, J., Yoon, S., Jung, K. H., Cheon, J., Kim, W., Kim, D., Lee, C. H., Kim, S., et al. (2019) · Europe PMC (PubMed Central) · Cited by 25
Sempere, L. F. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.944507 · Cited by 25
Fredj, Z., Azzouzi, S., Turner, A. P. F., Ali, M. B., & Mak, W. C. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.03.160 · Cited by 24
Tumor suppressor function of miR‑129‑5p in lung cancer
Li, G., Xie, J., & Wang, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10241 · Cited by 24
Chen, C., Tang, J., Xu, S., Zhang, W., & Jiang, H. (2020) · BioMed Research International · doi:10.1155/2020/2547902 · Cited by 24
RetractedAn entropy-driven DNA nanomachine for microRNA detection using a personal glucose meter
Wang, Q., He, Y., He, S., Yu, S., Jiang, Y., & Wang, F. (2023) · Chemical Communications · doi:10.1039/d2cc06479k · Cited by 24
MicroRNA and AU-rich element regulation of prostaglandin synthesis
Moore, A. E., Young, L. E., & Dixon, D. A. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9300-5 · Cited by 24
Stenvold, H., Dønnem, T., Andersen, S., Al‐Saad, S., Valkov, A., Pedersen, M. I., Busund, L., & Bremnes, R. M. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-9 · Cited by 24
Peng, L., Zhou, J., Liang, Z., Zhang, Y., Petti, L., Jiang, T., Gu, C., Yang, D., & Mormile, P. (2019) · Analytical Methods · doi:10.1039/c9ay00573k · Cited by 24
Wang, B., Yu, J., Sun, Z., Luh, F., Lin, D., Shen, Y., Wang, T., Zhang, Q., & Liu, X. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23203 · Cited by 25
Yang, Y.-L., Xu, L., Zhuo, F., & Wang, T. (2015) · Tumor Biology · doi:10.1007/s13277-015-3366-6 · Cited by 23
Kunz, M., Göttlich, C., Walles, T., Nietzer, S., Dandekar, G., & Dandekar, T. (2017) · Tumor Biology · doi:10.1177/1010428317706430 · Cited by 23
CRISPR-Cas12a coupled with cyclic reverse transcription for amplified detection of miRNA
Long, X., Li, J., Luo, T., Liu, H., Deng, Z., Ding, J., Gong, Z., Yang, Y., & Zhong, S. (2023) · Chemical Communications · doi:10.1039/d3cc01712e · Cited by 23
Stability of serum high-density lipoprotein-microRNAs for preanalytical conditions
Ishikawa, H., Yamada, H., Taromaru, N., Kondo, K., Nagura, A., Yamazaki, M., Ando, Y., Munetsuna, E., Suzuki, K. A. O., Ohashi, K., et al. (2016) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563216647086 · Cited by 23
How Ginsenosides Trigger Apoptosis in Human Lung Adenocarcinoma Cells
Han, X., Xue, Q., Zhang, Q., Li, C., Liu, X., Liu, J., Li, H., & Yang, J. (2019) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x19500885 · Cited by 24
Genomic medicine in non‐small cell lung cancer: Paving the path to personalized care
Sriram, K. B., Larsen, J. E., Yang, I. A., Bowman, R., & Fong, K. M. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01892.x · Cited by 26
Diagnostic Value of Circulating microRNAs for Lung Cancer: A Meta-Analysis
Shen, Y., Wang, T., Yang, T., Hu, Q.-J., Wan, C., Chen, L., & Wen, F. (2013) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2012.0370 · Cited by 22
MiR-205 functions as a tumor suppressor via targeting TGF-α in osteosarcoma
Yang, G., Zhang, P., Lv, A., Liu, Y., & Wang, G. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.12.010 · Cited by 22
Liu, Q. L., Kang, P.-J., Chen, Z., Shi, C., Chen, Y., & Yu, R. (2019) · Chemical Communications · doi:10.1039/c9cc06790f · Cited by 22
Metadata
- Authors
- Markou, A., Tsaroucha, E. G., Kaklamanis, L., Fotinou, M., Georgoulias, V., & Lianidou, E. S.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Sotiria General Hospital (GR)
- Onassis Cardiac Surgery Center (GR)
- University of Crete (GR)
- Corresponding author
- Lianidou, Evi S
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-01
- Volume
- 54
- Issue
- 10
- Pages
- 1696-1704
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2154551754
- Cited by
- 441
- References
- 39
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 14 · 2021: 16 · 2020: 21 · 2019: 21 · 2018: 18 · 2017: 31 · 2016: 26 · 2015: 34 · 2014: 42 · 2013: 33 · 2012: 51
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National and Kapodistrian University of Athens
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
- Keywords
- miR-21, microRNA-205, non-small cell lung cancer, prognostic factors, microRNA overexpression, overall survival, tumor recurrence, microRNA quantification
- MeSH terms
- Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Prognosis, Multivariate Analysis, Survival Analysis, Reverse Transcriptase Polymerase Chain Reaction, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review